Tyler E. Greenlee

Racial, Ethnic, and Insurance-Based Disparities Upon Initiation of Anti–Vascular Endothelial Growth Factor Therapy for Diabetic Macular Edema in the US

Nisha Malhotra, Tyler E. Greenlee, Amogh Iyer et al. · Ophthalmology · 2021 · 56 citations

Medicine, Insurance, Ophthalmology +12

Chloroquine and Hydroxychloroquine Toxicity

Weilin Song, Justin C. Muste, Tyler E. Greenlee et al. · American Journal of Ophthalmic Clinical Trials · 2020 · 42 citations · Full text

Medicine, Ophthalmology, Pharmacotherapy +13

Expanded Clinical Spectrum of Pentosan Polysulfate Maculopathy: A Macula Society Collaborative Study

Nieraj Jain, Albert Liao, Sunir J. Garg et al. · Ophthalmology Retina · 2021 · 35 citations

Medicine, Ophthalmology, Pathology +10

Fluctuations in macular thickness in patients with diabetic macular oedema treated with anti-vascular endothelial growth factor agents

Victoria Y. Wang, Blanche L. Kuo, Andrew X. Chen et al. · Eye · 2021 · 31 citations · Full text

Medicine, Ophthalmology, Pharmacotherapy +14

CONSEQUENCES OF LAPSES IN TREATMENT WITH VASCULAR ENDOTHELIAL GROWTH FACTOR INHIBITORS IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION IN ROUTINE CLINICAL PRACTICE

Tyler E. Greenlee, Victoria Y. Wang, Hannah Kang et al. · Retina · 2020 · 27 citations

Medicine, Ophthalmology, Pharmacotherapy +17